Company intelligence / Profile preview

Ysios Capital

San Sebastián, Basque Country, Spainysioscapital.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Ysios Capital does not have its own clinical results. Its portfolio includes over 70 products at clinical stage and has brought 19 products to market through investments in biotech ventures developing novel therapeutics for high unmet medical needs.

Industry: Investors

Partnerships

Collaborates with leading research institutions via its portfolio companies; specific partnerships are company-dependent within the investment portfolio

Beyond the preview

Go deeper on Ysios Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ysios Capital.

Explore the full profile